EZH2 and lung cancer: By enhancing the expression of CCL5, EZH2 facilitated the recruitment and aggregation of macrophages in lung cancer, led to the invasion of tumor cells, and accelerated the epithelial–mesenchymal transition (EMT) process of pancreatic cancer cells [26,27].